IRIS - Res&Arch Institutional Research Information System - Research & Archive

FERRARA, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.888
EU - Europa 1.837
AS - Asia 1.708
SA - Sud America 361
Continente sconosciuto - Info sul continente non disponibili 134
AF - Africa 53
OC - Oceania 2
Totale 6.983
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.765
SG - Singapore 769
UA - Ucraina 369
IE - Irlanda 302
SE - Svezia 285
BR - Brasile 284
RU - Federazione Russa 259
CN - Cina 247
VN - Vietnam 220
HK - Hong Kong 182
IT - Italia 136
DE - Germania 120
FR - Francia 109
FI - Finlandia 99
CA - Canada 61
GB - Regno Unito 61
KR - Corea 51
IN - India 37
JP - Giappone 29
BD - Bangladesh 24
IQ - Iraq 24
TR - Turchia 23
AR - Argentina 19
CH - Svizzera 18
ID - Indonesia 18
AT - Austria 17
EC - Ecuador 17
MX - Messico 17
ZA - Sudafrica 16
CO - Colombia 15
UZ - Uzbekistan 15
PK - Pakistan 14
MA - Marocco 12
MY - Malesia 12
VE - Venezuela 10
BE - Belgio 9
CR - Costa Rica 9
NL - Olanda 9
CW - ???statistics.table.value.countryCode.CW??? 8
PY - Paraguay 8
SA - Arabia Saudita 8
ES - Italia 7
HN - Honduras 7
KE - Kenya 7
PL - Polonia 7
CZ - Repubblica Ceca 5
LB - Libano 5
MD - Moldavia 5
PR - Porto Rico 5
GR - Grecia 4
IL - Israele 4
NI - Nicaragua 4
NP - Nepal 4
PH - Filippine 4
SV - El Salvador 4
AL - Albania 3
CL - Cile 3
DZ - Algeria 3
EU - Europa 3
GP - Guadalupe 3
HU - Ungheria 3
LT - Lituania 3
TN - Tunisia 3
UY - Uruguay 3
XK - ???statistics.table.value.countryCode.XK??? 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
AZ - Azerbaigian 2
BB - Barbados 2
BI - Burundi 2
GT - Guatemala 2
JM - Giamaica 2
JO - Giordania 2
KW - Kuwait 2
LY - Libia 2
PE - Perù 2
SC - Seychelles 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BF - Burkina Faso 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
GM - Gambi 1
HT - Haiti 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LV - Lettonia 1
MK - Macedonia 1
MN - Mongolia 1
OM - Oman 1
PA - Panama 1
Totale 6.857
Salva come PNG Salva come JPEG
Città #
Singapore 506
Chandler 343
Dublin 302
San Jose 281
Hong Kong 181
Jacksonville 163
San Mateo 154
Ashburn 146
Santa Clara 124
Boardman 118
Council Bluffs 99
Moscow 88
Medford 86
Princeton 86
Dong Ket 81
Beijing 76
Lauterbourg 76
Ann Arbor 73
Des Moines 57
Wilmington 56
Seoul 51
Altamura 43
The Dalles 43
Ho Chi Minh City 42
Lawrence 41
New York 41
Perugia 38
Andover 37
Hanoi 33
Tokyo 29
Los Angeles 25
Piscataway 23
Norwalk 21
Saint Petersburg 21
São Paulo 21
Woodbridge 20
North Bergen 15
Munich 14
Edmonton 13
Baghdad 11
Falls Church 11
Izmir 11
Rio de Janeiro 11
Helsinki 10
Shanghai 10
Brussels 9
Chicago 9
Guayaquil 9
Haiphong 9
Phoenix 9
Chennai 8
Tashkent 8
Willemstad 8
Dallas 7
Dearborn 7
Nairobi 7
San José 7
Toronto 7
Ankara 6
Casablanca 6
Da Nang 6
Denver 6
Frankfurt am Main 6
Houston 6
Jakarta 6
Johannesburg 6
Lausanne 6
Montreal 6
Nuremberg 6
San Paolo di Civitate 6
Stockholm 6
Brooklyn 5
Kuala Lumpur 5
Miami 5
Porto Alegre 5
San Francisco 5
Turku 5
Amsterdam 4
Asunción 4
Auburn Hills 4
Belo Horizonte 4
Bengaluru 4
Buffalo 4
Changsha 4
Chisinau 4
Dhaka 4
Falkenstein 4
Fortaleza 4
Guangzhou 4
Guarulhos 4
Karachi 4
London 4
Managua 4
Poplar 4
San Salvador 4
Três Lagoas 4
Vienna 4
Atlanta 3
Bogotá 3
Boston 3
Totale 4.032
Salva come PNG Salva come JPEG
Nome #
Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children. 165
A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis. 144
Basi genetiche della predisposizione alla tubercolosi (TB) ed alle micobatteriosi non tubercolari. 135
A decade of interferon-γ release assays: quest for the holy grail to diagnose latent infection with mycobacterium tuberculosis? 130
Il trattamento della tubercolosi. 124
Combination fluticasone end salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children 118
[Are targeted interventions needed in foreigner workers with latent tubercular infection? A study on anti-tubercular treatment compliance among health care workers] 118
Long term Moxifloxacin in complicated tuberculosis patients with adverse reactions or resistance to first line drugs. 114
Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children. 114
Acute exacerbation of idiopathic pulmonary fibrosis: a clinical review 113
Cough mechanical assistance in neuromuscular patients with respiratory failure: a retrospective evaluation 111
A method to quantify mycobacteria infection of cells from in vitro experiments 111
Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis: an open-label phase 1 safety trial. 111
Chronic empyema: importance of preventing complications in the management of pleural effusions 108
A screening for latent tuberculosis infection among candidates to anti-tumor necrosis factor-alpha agents using a whole blood interferon-gamma test 107
Intra-abdominal bleeding during treprostinil infusion in a patient with pulmonary arterial hypertension 107
Clinical and operational value of the XDR-TB definition. 102
Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases. 99
Community acquired pneumonia in internal medicine: a one-year retrospective study based on pneumonia severity index. 96
Combination fluticasone and salmeterol vs fixed dose combination budesonide and formoterol in adults and children 95
Trends and challenges in tuberculosis in a medium-sized southern European setting 95
Interferon-gamma-release assays detect recent tuberculosis re-infection in elderly contacts. 93
Fluoroquinolones: are they essential to treat multidrug-resistant tuberculosis? 93
Interferon-{gamma} release assays for the diagnosis of latent M. tuberculosis infection: A systematic review and meta-analysis. 92
Clinical use of Levofloxacin in the long term treatment of drug resistant tuberculosis. 90
Sarcoidosi: patogenesi 90
Alveolar macrophages produce CCL18 during early phases infection by M. tuberculosis 87
C’è esigenza di interventi mirati nei lavoratori stranieri affettida infezione tubercolare latente? Uno studio sulla compliancealla terapia antitubercolare in operatori sanitari 86
Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis. 84
Management of multidrug-resistant tuberculosis in Italy. 82
Using ELISpot technology to improve the diagnosis of tuberculosis infection: from the bench to the T-SPOT.TB assay 82
Gender and other risk factors for multidrug-resistant (MDR) tuberculosis (TB) among migrants to Milan, Italy 82
Serum reactome induced by Bordetella pertussis infection and Pertussis vaccines: qualitative differences in serum antibody recognition patterns revealed by peptide microarray analysis 82
Epidemiology and clinical managment of XDR-TB: a systematic review. 81
Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. 81
Xpert MTB/RIF test for tuberculosis. 81
Risk factors associated with pulmonary tuberculosis: smoking, diabetes and anti-TNFα drugs. 81
Clinical use of levofloxacin in the long term treatment of drug resistant tuberculosis 81
T-Cell Therapy: Options for Infectious Diseases 81
Corticosteroids for idiophatic pulmonary fibrosis. 80
Mycobacterium tuberculosis induces CCL18 in human macrophages. 78
Macrolides for chronic asthma. 77
Dossier Tubercolosi. La tubercolosi agli inizi del XXI secolo: diagnosi e terapia 77
Latent tuberculous infection among foreign-born individuals applying to shelters in the metropolitan area of Milan 77
Macrolides in the treatment of asthma and cystic fibrosis. 75
Il trattamento della Tubercolosi 74
Routine Hospital Use of a New Commercial Whole Blood Interferon-γ Assay for the Diagnosis of Tuberculosis Infection. 73
Tuberculosis in prisons in sub-Saharan Africa--the need for improved health services, surveillance and control. 73
Delay and inequalities in the treatment of idiopathic pulmonary fibrosis: The case of two Nordic countries 73
TB or not TB: update from the ERS Respiratory Infection Assembly 10. 73
Macrolides for chronic asthma. 72
Differences among multidrug-resistant tuberculosis patients in two metropolitan areas 72
Intravenous Immunoglobulin (IVIg) for Refractory and Difficult-to-treat Infections. 72
Tuberculosis in prisons: anatomy of global neglect. 72
Exploring the immune response against Mycobacterium tuberculosis for a better diagnosis of the infection. 71
Macrolides for chronic asthma 71
Mutational status predicts the risk of thromboembolic events in lung adenocarcinoma 71
Screening of immigrants in the UK for latent tuberculosis. 70
Use of an IGRA test for prescribing latent TB infection therapy in 374 immigrants applying to night shelters in Milan, Italy 70
The best on infections: update from the 2010 ERS Congress. 69
Micobatteriosi non tubercolari 68
High risk of tuberculosis in health care workers in Romania. 68
Performance of tests for latent tuberculosis in different groups of immunocompromised patients. 66
Monitoring the quality of laboratories and the prevalence of resistance to antituberculosis drugs: Italy, 1998-2000. 66
Blood tests for diagnosis of tuberculosis - Authors' reply. 66
Validation of the tuberculin skin test cut-off in BCG vaccinated individuals using the QuantiFERON-TB Gold 65
New tools for a better diagnosis of latent tuberculosis infection 65
Corticosteroids for IPF: a systematic review 62
Management of MDR and rifampicin-resistant TB cases in Italy, 1995-1999 61
Recurrent respiratory infections and unusual radiology: a woman with Kartagener's syndrome 60
I nuovi test per la diagnosi di infezione tubercolare. 58
Severe pneumonia after intravesical BCG instillation in a patient with invasive bladder cancer: case report and literature review 58
Linezolid to treat extensively drug-resistant TB: retrospective data are confirmed by experimental evidence 57
Isoniazid preventive treatment: predictors of adverse events and treatment completion. 57
Extra-pulmonary tuberculosis and Xpert® MTB/RIF: all about meta-analyses? 57
Idiopathic pulmonary fibrosis in Sweden: report from the first year of activity of the Swedish IPF-Registry 57
Macrolides for chronic asthma. 56
Molecular diagnosis of tuberculosis in a north Italian clinical setting: results of routine use of a commercial LCR-based test 55
No association between Birt-Hogg-Dubé syndrome skin fibrofolliculomas and the first 10 described human polyomaviruses or human papillomaviruses. 55
Extensively drug-resistant tuberculosis, Italy and Germany. 53
High risk of tuberculosis in health care workers in Romania 52
Need for combined interventions and operational research to tackle tuberculous meningitis 49
Treatment of idiopathic pulmonary fibrosis: a position paper from a Nordic expert group 47
Immune recognition surface construction of Mycobacterium tuberculosis epitope-specific antibody responses in tuberculosis patients identified by peptide microarrays 47
Tuberculosis: Novel opportunities to control an old disease. 46
Humoral immune profiling of mycobacterial antigen recognition in sarcoidosis and Löfgren’s syndrome using high-content peptide microarrays 46
Totale 6.983
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.506
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.506
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022465 0 0 0 46 11 7 12 207 3 8 58 113
2022/20231.072 98 143 7 110 95 147 0 44 393 1 26 8
2023/2024362 21 57 22 10 4 3 59 3 68 5 53 57
2024/2025807 4 110 84 10 100 12 26 61 177 52 128 43
2025/20262.157 141 171 138 304 245 175 333 91 324 172 41 22
2026/2027620 41 63 101 415 0 0 0 0 0 0 0 0
Totale 6.983